Skip to main content
. 2021 Apr 29;13(9):2157. doi: 10.3390/cancers13092157

Figure 1.

Figure 1

Impact of glutaminase (GLS1) mRNA on survivals using The Cancer Genome Atlas (TCGA) data portal cohort. (A) GLS1 mRNA expression and overall survival with a medium cutoff, (B) GLS1 mRNA expression and overall survival with a quartile cutoff, (C) mRNA expression and disease-free survival with a medium cutoff and (D) GLS1 mRNA expression and disease-free survival with a quartile cutoff. Dotted lines represent 95% confidence interval (CI).